Rebecca Araujo - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Rebecca Araujo's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Rebecca Araujo
Verified
Associate Editor, AAOS Now and Contributing Writer, Doc Wire News
United States
Beats
Travel , Mental Health , Science , Parenting , Teenagers
Extreme Apple fanboy topics.
Content
By Rebecca Araujo Verified| Doc Wire News Verified The use of anabolic agents for the treatment of osteoporosis is not associated with increased risk of development of primary bone malignancy, according to a study in the Journal of the AAOS. “Although many risk factors for the development of primary bone tumors have been identified, there has been minimal human research into whether medications, specifically bone-forming medications, increase the likelihood of developing primary bone malignancies,” wrote Christopher L.
By Rebecca Araujo Verified| Doc Wire News Verified New data from a study funded by the National Institutes of Health reported that children with have a distinct biomarker that is not present in other children with COVID-19. MIS-C is a rare condition linked with SARS-CoV-2 infection that is marked by external and internal inflammation. The study, which was published in Cell Reports Medicine, was conducted by Charles Y. Chiu, MD, of the University of California San Francisco, and colleagues from other institutions.
By Rebecca Araujo Verified| Doc Wire News Verified The use of anabolic agents for the treatment of osteoporosis is not associated with increased risk of development of primary bone malignancy, according to a study in the Journal of the AAOS. “Although many risk factors for the development of primary bone tumors have been identified, there has been minimal human research into whether medications, specifically bone-forming medications, increase the likelihood of developing primary bone malignancies,” wrote Christopher L.
Company Info
Doc Wire News